top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advances and Novel Treatment Options in Metastatic Melanoma
Advances and Novel Treatment Options in Metastatic Melanoma
Autore Facchiano Antonio
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (528 p.)
Soggetto topico Medicine
Soggetto non controllato melanoma
invasion
WNT5A
MARCKS
phosphorylation
MANS peptide
nanoparticles
cell therapy
tumor microenvironment
sex/gender
sex-hormones
immunity
microRNAs
immunotherapy
BRAF-mutant melanoma
BRAF inhibitor
mechanism of action
targeted therapy
tumour microenvironment
plasmacytoid dendritic cells
lactate dehydrogenase
TLR
interferon
CXCL10
TPC2
HIPPO
SOCE
metastasis
essential oils
angiogenesis
apoptosis
uveal melanoma (UM)
metastatic uveal melanoma (mUM)
prognostication
adjuvant therapy
metastatic therapy
metastatic dormancy
liver-directed-therapies
targeted-therapy
combined therapy
protein tyrosine phosphatase
PTPs inhibitors
melanoma immune infiltrate
BRAF inhibitors
microenvironment
resistance
therapy
therapeutic resistance
exosomes
extracellular vesicles
diagnosis
prognosis
ctDNA
liquid biopsy
prediction
patient stratification
BRAF
arthralgia
rheumatoid arthritis
carbonic anhydrase
hedgehog
cyclopamine
small molecules
acetazolamide
motility
metalloproteinases
FAK
cancer
mucosal melanoma
nivolumab
pembrolizumab
ipilimumab
radiotherapy
cholinergic system
acetylcholine
muscarinic receptors
nicotinic receptors
melanoma metastasis
ShcD adaptor protein
amoeboid motility
Rac1
DOCK4
melanoma PDX
target therapy
cancer stem cells
slow cycling phenotype
drug resistance
OXPHOS
lipid metabolism
cancer associated fibroblast
melanomagenesis
biomarkers
checkpoint inhibitor
PD-1
melanoma markers
cytokines
machine learning
Support Vector Machine
principal component analysis
BCL2L10
STAT3
cytotoxicity
survival
ABT-737
Bcl-2 family
ML258
HuR
MITF
metastases
siRNA
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557612103321
Facchiano Antonio  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Biomarkers Used for the Diagnosis of Diseases
Biomarkers Used for the Diagnosis of Diseases
Autore Nimse Satish Balasaheb
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (120 p.)
Soggetto topico Research & information: general
Soggetto non controllato SERS
LPS
bacteria
endotoxin
lipid A
silver nanorods
creatinine
ZnO nanowires
piezo-enzymatic-reaction effect
self-powered biosensor
immunosensors
electrochemical immunosensors
biosensors
voltammetric immunosensors
amperometric immunosensors
impedimetric immunosensors
eletrochemiluminescent immunosensors
cysteine
biothiols
cystinuria
portable
fluorimeter
bio-imaging
cancer
bladder cancer
prostate cancer
urinary biomarkers
urinary VOCs
machine olfaction
GC-IMS
GC-TOF-MS
cancer markers
immune checkpoints
PD-1
PD-L1
high-aspect-ratio microfluidic channel
parallelogram cross-section
monodisperse droplet
droplet generation
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566479803321
Nimse Satish Balasaheb  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Immunology
Cancer Immunology
Autore Subramanian Subree
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (316 p.)
Soggetto topico Medicine
Soggetto non controllato NKG2D
CAR T
IL-7
prostate cancer
cell therapy
CD19-CAR-T
B cell aplasia
KIR
PD-1
inhibitory CAR
tumor-infiltrating lymphocytes
tumor microenvironment
immunotherapy
NK cells
cancer stem cells (CSCs)
antibody-dependent cellular cytotoxicity (ADCC)
differentiation
cytotoxicity
IFN-γ
osteoclasts
MICA/B mAb
DNA methylation
RNA methylation
S-adenosylmethionine (SAM)
cancer
innate immunity
adaptive immunity
T cells
m6A
PD-L1
resistance
immune checkpoints
cancer vaccine
combination immunotherapy
TCR diversity
organ transplantation
carcinoma
epidemiologic studies
immunosuppression
CTLA-4
Treg cells
immune checkpoint inhibitors
CD28
antigen-presenting cells
IL15
colon cancer
melanoma
uveal
BAP1
anti-PD-1
anti-CTLA-4
TIL
classical and endemic Kaposi Sarcoma
systemic treatment
multi-state modelling
treatment free interval
chemotherapy
interferon
triple negative breast cancer
immunomodulation
bispecific antibody
sortase A
chemo-enzymatic approach
anti-CD20 antibody
Fab
BiFab
colorectal cancer
dendritic cells
Atypical Chemokine Receptor 4 (ACKR4)
T-cell priming
immune checkpoint blockade
primary liver cancer
kynurenine pathway
immune evasion
indoleamine 2,3 dioxygenase 1
tryptophan 2,3 dioxygenase 2
IDO inhibitor
antigen presenting cells
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557349203321
Subramanian Subree  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Immunotherapy and The Regulatory Immune System in Blood Cancers: From Mechanisms to Clinical Applications
Immunotherapy and The Regulatory Immune System in Blood Cancers: From Mechanisms to Clinical Applications
Autore Young Ken H
Pubbl/distr/stampa Frontiers Media SA, 2019
Descrizione fisica 1 electronic resource (127 p.)
Soggetto topico Medicine
Oncology
Soggetto non controllato Immune checkpoint
Lymphoma
PD-1
target therapy
microenvironment
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Immunotherapy and The Regulatory Immune System in Blood Cancers
Record Nr. UNINA-9910557224703321
Young Ken H  
Frontiers Media SA, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments
Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments
Autore Uchino Junji
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (258 p.)
Soggetto topico Medicine
Soggetto non controllato non-small cell lung cancer
previously treated patients
phase I/II trial
chemotherapy
docetaxel
S-1
immunotherapy
rechallenge
retrospective analysis
pulmonary pleomorphic carcinoma
prognostic factor
glucose transporter 1
lung cancer
multiple cancers
metastasis
sequencing
mutation
genomic diagnosis
FDG-PET
immune checkpoint inhibitor
PD-1
prognosis
RAD51B methylation
PD-L1 expression
predictive biomarker
PD-1 blockade
interstitial lung disease
pulmonary fibrosis
radiology and other imaging
non-small-cell lung cancer
epidermal growth factor receptor
tyrosine kinase inhibitors
TP53 mutations
responsiveness
targeted therapy
network meta-analysis
stage IIIA-N2
surgery
immune checkpoint inhibitors
biomarker
nonsmall cell lung cancer
HIP1R
PD-L1
RUNX1
methylation
survival
EGFR-TKI
T790M
osimertinib
immune-related adverse events
endocrine disorders
tumor-bearing patients
PD-1 inhibitors
PD-L1 inhibitors
meta-analysis
nivolumab
Expanded Access Program
real-world data
daily practice
prognostic factors
NSCLC
KRAS
DNA polymerase beta
platinum-based first-line
adjuvant chemotherapy
β-catenin
lung neoplasms
nucleotide-diphosphate kinase
recurrence
unresectable
salvage surgery
oligometastasis
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Non-small Cell Lung Cancer
Record Nr. UNINA-9910557489703321
Uchino Junji  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Oncolytic Virus Immunotherapy
Oncolytic Virus Immunotherapy
Autore Marchini Antonio
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (366 p.)
Soggetto topico Medicine
Clinical & internal medicine
Soggetto non controllato oncolytic viruses
melanoma
immunotherapy
checkpoint inhibitors
combinatory therapy
reovirus
oncolytic virus
adenovirus
oncolytic
virotherapy
targeting
immunogenic cell death
αvβ6 integrin
oncolytic adenovirus
cancer immunotherapy
multi-stage
immunostimulatory
arming
HSV-1
clinical trials
newcastle disease virus
NDV
cancer
immune checkpoint inhibitor
PD-1
PD-L1
CTLA-4
type I interferon
herpes simplex virus
retargeted virus
tropism retargeting
tumor
checkpoint inhibitor
vaccination
antigen-agnostic vaccination
HER2
parvovirus
tumor microenvironment
combination therapy
glioblastoma
pancreatic cancer
colorectal cancer
measles virus
vector engineering
immune checkpoint blockade
antitumor immune response
delivery
genetic modification
biomarkers
personalized oncolyticvirotherapy
class I HLA
immunosurveillance
immunoediting
oncogenic signaling
RAS
DNA methyltransferase inhibitor (DNMTi)
viral mimicry
epigenetic silencing
adoptive T cell therapy
CAR T cell
pancreatic ductal adenocarcinoma
vesicular stomatitis virus
small molecule
cancer immune therapy
cancer therapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566462203321
Marchini Antonio  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Role of Medical Imaging in Cancers . Volume 1
Role of Medical Imaging in Cancers . Volume 1
Autore Fanti Stefano
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (312 pages)
Soggetto topico Medicine
Soggetto non controllato positron emission tomography
head and neck neoplasms
neovascularization
pathologic
PET/CT
urothelial carcinoma
bladder cancer
upper tract urothelial carcinoma
survival
PET
PSMA
prostate
DCFPyL
DCFBC
PSMA-1007
ovarian cancer
relapse
SUVmax
targeted therapy
prognosis
soft tissue sarcoma (STS)
pazopanib
dynamic 18F-FDG PET/CT
SUV
two-tissue compartment model
magnetic resonance imaging
machine learning
diffusion
perfusion
texture analysis
squamous cell carcinoma of the head and neck
diffusion-weighted imaging
malignant pleural mesothelioma
pleural dissemination
empyema
pleural effusion
mCRPC
SPECT/CT
Computer-assisted diagnosis
XOFIGO
Therapy response assessment
circulating miRNAs
breast cancer
imaging parameters
PET/MRI
biomarkers
triple negative breast cancer
VCAM-1
SPECT imaging
sdAbs
Hounsfield unit
computed tomography
adipose tissue
precision oncology
FDG-PET/CT
PERCIST
metastatic breast cancer
prostate cancer
18F-FACBC
recurrence
meta-analysis
review
meningioma
somatostatin receptor
neuroimaging
radionuclide therapy
breast
imaging
marker
radiomics
Yin Yang 1
PDAC
Mesothelin
noninvasive imaging
receptor status
molecular imaging
nuclear medicine
guidelines
overutilization
epistemology
consensus
mantle cell lymphoma
18F-FDG PET/CT
Deauville criteria
Radium-223
FDG
castrate resistant prostate cancer
programmed cell death 1 receptor
diagnostic imaging
CTLA-4 Antigen
Immunotherapy
Adoptive
radioactive tracers
radionuclide imaging
CD8-Positive T-Lymphocytes
PI-RADS
diffusion kurtosis imaging
dynamic contrast-enhanced magnetic resonance imaging
68Gallium-PSMA PET/CT
prostate-specific-antigen
PSA kinetics thresholds
biochemical recurrence
optimal cutoff level
non-small-cell lung cancer
circulating tumor cells
immunotherapy
response to treatment
head and neck cancer
HPV
EBV
p16
Molecular imaging
miRNA expression
radiogenomics
radiomic
diagnosis
biomarker
glioblastoma
radiation therapy
MRI
diffusion tensor imaging
Hodgkin lymphoma
diffuse large B-cell lymphoma
staging
response assessment
locally advanced cervical cancer
concurrent chemoradiotherapy
treatment response
follow up
cystic tumor
International Consensus Guidelines
intraductal papillary mucinous neoplasms
pancreatic neoplasms
PD-1
PD-L1
response to therapy
NSCLC
positron-emission tomography
single-photon emission computed tomography
immune checkpoint inhibitors
gold nanoparticle
heat shock protein 70
spectral-CT
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557432103321
Fanti Stefano  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Role of Medical Imaging in Cancers . Volume 2
Role of Medical Imaging in Cancers . Volume 2
Autore Fanti Stefano
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (228 p.)
Soggetto topico Medicine
Soggetto non controllato positron emission tomography
head and neck neoplasms
neovascularization
pathologic
PET/CT
urothelial carcinoma
bladder cancer
upper tract urothelial carcinoma
survival
PET
PSMA
prostate
DCFPyL
DCFBC
PSMA-1007
ovarian cancer
relapse
SUVmax
targeted therapy
prognosis
soft tissue sarcoma (STS)
pazopanib
dynamic 18F-FDG PET/CT
SUV
two-tissue compartment model
magnetic resonance imaging
machine learning
diffusion
perfusion
texture analysis
squamous cell carcinoma of the head and neck
diffusion-weighted imaging
malignant pleural mesothelioma
pleural dissemination
empyema
pleural effusion
mCRPC
SPECT/CT
Computer-assisted diagnosis
XOFIGO
Therapy response assessment
circulating miRNAs
breast cancer
imaging parameters
PET/MRI
biomarkers
triple negative breast cancer
VCAM-1
SPECT imaging
sdAbs
Hounsfield unit
computed tomography
adipose tissue
precision oncology
FDG-PET/CT
PERCIST
metastatic breast cancer
prostate cancer
18F-FACBC
recurrence
meta-analysis
review
meningioma
somatostatin receptor
neuroimaging
radionuclide therapy
breast
imaging
marker
radiomics
Yin Yang 1
PDAC
Mesothelin
noninvasive imaging
receptor status
molecular imaging
nuclear medicine
guidelines
overutilization
epistemology
consensus
mantle cell lymphoma
18F-FDG PET/CT
Deauville criteria
Radium-223
FDG
castrate resistant prostate cancer
programmed cell death 1 receptor
diagnostic imaging
CTLA-4 Antigen
Immunotherapy
Adoptive
radioactive tracers
radionuclide imaging
CD8-Positive T-Lymphocytes
PI-RADS
diffusion kurtosis imaging
dynamic contrast-enhanced magnetic resonance imaging
68Gallium-PSMA PET/CT
prostate-specific-antigen
PSA kinetics thresholds
biochemical recurrence
optimal cutoff level
non-small-cell lung cancer
circulating tumor cells
immunotherapy
response to treatment
head and neck cancer
HPV
EBV
p16
Molecular imaging
miRNA expression
radiogenomics
radiomic
diagnosis
biomarker
glioblastoma
radiation therapy
MRI
diffusion tensor imaging
Hodgkin lymphoma
diffuse large B-cell lymphoma
staging
response assessment
locally advanced cervical cancer
concurrent chemoradiotherapy
treatment response
follow up
cystic tumor
International Consensus Guidelines
intraductal papillary mucinous neoplasms
pancreatic neoplasms
PD-1
PD-L1
response to therapy
NSCLC
positron-emission tomography
single-photon emission computed tomography
immune checkpoint inhibitors
gold nanoparticle
heat shock protein 70
spectral-CT
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557309503321
Fanti Stefano  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
The Immunology and Biology of Brain Tumors
The Immunology and Biology of Brain Tumors
Autore Graner Michael
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (88 p.)
Soggetto topico Medicine
Soggetto non controllato vaccine therapy
oncoantigen
tumor associate antigen
tumor angiogenesis
high-grade glioma
pituitary neuroendocrine tumors
VEGF
Treg
TAM
PD-1
PD-L1
tumor microenvironment (TME)
glioblastoma multiforme (GBM)
GBM-associated macrophages (GAMs)
exosomes
oncomiR-21
STAT3 inhibitor
glioma
diffusion tensor imaging
generalized q-ball imaging
treatment-related effects
multiple resections
adrenal insufficiency
Addison’s disease
bevacizumab
cerebral radiation necrosis
craniopharyngioma
inflammation
checkpoint inhibitors
Interleukin-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557665403321
Graner Michael  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
The Shaping of Cancer by the Tumour Microenvironment and Its Relevance for Cancer Therapy
The Shaping of Cancer by the Tumour Microenvironment and Its Relevance for Cancer Therapy
Autore Madureira Patrícia Alexandra Saraiva
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (307 p.)
Soggetto topico Medicine
Soggetto non controllato hypoxia
macrophages
colon cancer
tumor microenvironment
immune cell infiltration
prognosis
feline mammary carcinoma
PD-1
PD-L1
CTLA-4
TNF-α
biomarkers
immunotherapy
cancer
histone modification
inhibitor
KDM5B
molecular docking
repurposing
cancer acidity
hyperosmolarity
cross-presentation
tumour microenvironment
syngeneic model
prostate cancer
radiotherapy
preclinical modelling
myeloid-derived suppressor cells
biomarker
stroma
cancer-associated fibroblast (CAF)
extracellular matrix (ECM)
cytokine/chemokine
growth factors
pro- and anti-tumor immune cells
immunomodulatory roles
radiotherapy dose fractionation
radioresistance
radiosensitivity
breast cancer
S100A10 (p11)
tumor growth
tumor progression
metastasis
carcinoma
mammary gland
triple negative
pre-metastatic niche
pro-inflammatory cytokines
clinical trials
evolutionary therapy
darwinian evolution
cancer cells subpopulations
diclofenac
koningic acid
spheroid
3D co-culture
microenvironment
resistance
myeloid cells
cancer development
molecular subtypes of pancreatic cancer
chemotherapy response
pancreatic stellate cells
regulatory T cells
tumor-associated macrophages
myeloid derived suppressor cells
glioblastoma (GB)
Hypoxia Inducible Factor (HIF)
glioma stem cells (GSC)
oxidative stress
reactive oxygen species
plasmin
plasminogen
S100A10
uPA
uPAR
PAI-1
PAI-2
cancer stem cells
cancer recurrence
therapeutic resistance
signaling pathways
targeted therapy
head and neck cancer
lung cancer
bladder cancer
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557354203321
Madureira Patrícia Alexandra Saraiva  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui